Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

94 India * Indinavir

12th World AIDS Conference

-Keyword

Abstract--

-Keyword

Abstract

across the Bangladesh/
an urban slum of South
distance truck drivers in
V related responses in
HIV/Marriage: A risk in
lood donors from USA,
year study in Calcutta,
eurotoxoplasmosis in
ex work - Bangalore,
ctivism/Blood safety in
afer blood transfusion!/
s in Salem, Tamil Nadu,
mong IDUs of Calcutta,
ng rural men in Gujarat,
g drug users in Manipur,
ng truck drivers in South
h IDUs on Bangladesh/
ds or family in Bombay,
project in West Bengal,
ern Rajasthan State of
h hostels in Bangalore,
ponding to HIV/AIDS in
esponse to HIV/AIDS in
iving with HIV/AIDS in
n UK ASO and NGOs in
ss sectoral networks in
IV-2 strains from Pune,
-2 infection in Calcutta (
S in Chennai (Madras),
ected patients in South
prevention in Bombay,
ng sex workers in Pune,
ndarban, West Bengal,
gay" support groups in
ostitution of Rajasthan,
ance study in Mizoram,
87-1996, West Bengal,
d control of HIV/AIDS in
rucking industry/AIDS,
icators: A case study in
ds in incidence of HIV in
n in Chandigarh, North
OPD clinic, Bangalore,
DS patients in Manipur,
ted individuals in Pune,
mmunities in Rajasthan,
ant recepients in South
y of HIV-1/2 in Mumbai,
n in rural Maharashtra,
al students in Jodhpur,
n in Mumbai (Bombay),

border/Empowering young women b
/Health awareness and health seekin
/Risk behaviour, use of condoms and
- Impact as a product of historicizatio
for acquiring HIV/Marriage: A risk in,Jamaica, Malaysia, and Thailand/D
/Stool pathogens in diarrhea associat
/Serodiagnosis of neurotoxoplasmos
/Medical care and HIV/AIDS preventi
through judicial and NGO activism/BI
marches towards safer blood transfu
/HIV/AIDS awareness and interventi
/Behavioural modification through ou
/Perceptions of sexually transmitted
/Behavioural change communication
/Intervention programme among truc
border/Harm reduction and commun
/Are married women talking about Al
/Young people's sexual health projec
/A survey of knowledge of AIDS in pa
/HIV/AIDS education programme am
/Facilitating strategic planning with N: Exploring the gap between positive
/Sharing experience from a network f,Caribbean, Romania, Ukraine and R: A case study from West Bengal/Dev
/Isolation and preliminary characteriz
) with a special reference to blood don
/Correlation between CD4/CD8 and t
/Immunological and virological analy
/Developing strong and committed gr
/Experiences in peer education appr
/Sexual health management progra
/Social and individual constraints und
/Impact of HIV intervention program
/An HIV surveillance study in Mizora
/Changing pattern of HIV infection in
/National policy for prevention and co

23557
23566
24115
24146
24315
31192
31222
32223
32420
33205
33208
33250
33338
33342
33349
33369
408*/33386
33446
33491
33545
33579
34149
34155
34280
34331
34374
42128
42130
42189
42395
43174
43249
43297
43337
43354
43447
43491
44118

nda/Baseline survey of
ermany/Time-ordered
4 T cells as prognostic
S care/Cost and quality
ifornia/HIV prevention
cal issues/Developing
amme using prevention
between immunologic indices

for STD case management in p 33229:Useful and efficient tools for st 259*/33443
/Plasma immune activation mar 42181
for the analysis of a program for 42217
provide evidence of successes 43439
for assessing AIDS program eff 44315: A case study in India/Evaluati 44317
and thymic mass in HIV infected p 21129

and the trucking industry/AIDS, 541*/44200
/Evaluation of national AIDS control p 44317
and the States/Meta-analysis and th 60033: Their knowledge and attitude toward 60041
/Out patient management of 745 HIV 60054
/Survival of AIDS patients in Manipur, 60078
/Seroprevalence of toxoplasma amo 60091
/Implementing sexual health promoti 60142
/HIV infection in renal transplant rece 60233
/The natural history of HIV-1/2 in Mu 60331
/Effect of counseling and intervention 60347
/Collaboration on HIV/AIDS educatio 60351
/Risk factors associated with child pr 60457

S/Developing symptom to assess health outcomes in pers
B and A in French West Indies /Identification of human immunodefi
lian experience among indigenous people/Challenge to prevent
vention/The role of the languages in HIV/AIDS preve
nd to develop their own approach to AIDS prevention
f HIV infection among indigent patients/Epidemiology of HIV inf
n HIV positive patients/ Indinavir-associated facial atrophy in HIV
nging from nelfinavir- to indinavir-containing regimens and assoc
reactivity with ritonavir/ Indinavir-induced urticaria and leukocyto
onmental temperature/ Indinavir-related nephrolithiasis is associ
ing either ritonavir (R), Indinavir or saquinavir (S) in 1749 patients
500 CD4 cells/mm3/ (IDV) in combination with zidovu
rvival on triple therapy:, ritonavir or saquinavir combined, HIV-infected patients/ with stavudine vs. IDV alone vs.
n HIV infected patients/ (Crixivan~) in combination with t
inistered with ritonavir/ can be taken with regular meals
munologic parameters/ pharmacokinetics and their corre
egimen: A pilot study/ 12 hour dosing an alternative to 8
ation bottleneck during therapy causes a genetic drift in t
unction associated with /Change in renal function associ
T + ddl vs. AZT + 3TC + ) on T-cell function and apoptosis
y than either ritonavir or in HIV infected antiretroviral naiv
omparing ritonavir and in 1251 previously treated patien
herapy (d4T + 3TC + ) in the progression of chronic HI
ir-saquinavir versus an containing triple combination reg
avir soft-gel-capsule or as part of combination triple ther
in patients treated with who experience virus load declin
een plasmatic levels of and inmunologic and virologic pa
teen week follow-up of sulfate (IDV) administered q 8 ho
er suboptimal dosing of /Effectiveness of a systematic ed
viral load/Response to in HIV-infected patients failing to
s a rescue therapy after failure/Ritonavir + saquinavir as
of nephrolithiasis due to /Urine acidification and the risk of
nce/Effect of nelfinavir/ /delavirdine in HIV+ patients with
elfinavir substitution for or ritonavir/saquinavir in HIV+ su
herapy/Saquinavir vs in triple drug therapy/Saquinavir
with zidovudine (ZDV), (IDV) and lamivudine (3TC) in HI
66) in combination with (IDV) [DMP 266-003, Cohort IV]/
complaints in relation to plasma levels in HIV-infected pat
ment of renal function in treated patients/Sterile leucocyt
quone suspension and have minimal pharmacokinetic in
r therapy/The loin pain/ syndrome and urolithiasis associ
y in the development of induced renal stones/Evaluation
rategies/Managing the /nevirapine interaction via US pre
0 CD4 count/Impact of with zidovudine and lamivudine
ith HCV-HIV/lmpact of (protease inhibitor) on HCV viral I
y of efavirenz (EFV) + (IDV), versus EFV + zidovudine (
with nevirapine (NVP), (IDV), and lamivudine (3TC)/Se
r ZDV plus 3TC plus (IND)/A comparison between se
stivaTM, DMP 266) and (IDV) versus indinavir in HIV-1 in
e/Co-administration of and nelfinavir: Pharmacokinetics
s a salvage regimen for or ritonavir resistance/Ritonavir,
V) in combinations with (IDV), zidovudine (ZDV), lamivu
mbinations-combining (IDV) with ritonavir (RTV): Result
and two dose levels of compared to zidovudine, lamivu
D4/mm3/AZT + 3TC + vs d4T + 3TC + indinavir for HIV i
etween nevirapine and and correlation with antiviral acti
esults of switching from to nelfinavir/Protease inhibitor-a
triple therapy including /Clinical remission and prolongu
r prolonged failure with or ritonavir/Salvage therapy usin
in patients treated with (IDV)/Saliva as a possible speci
triple therapy including /HIV-1 proviral DNA and plasma
mbination with 3TC and in the context of a population-bas
bination treatment with /Low frequency of genotypic mut
Relationships between (IDV) pharmacokinetics and anti
ected patients receiving /Therapeutic drug monitoring in
y/Low plasma levels of (IDV) are highly predictive of virol
00 cps/ml/Switch from (IDV) to nelfinavir (NFV) in patien
by gender in a study of (IDV) alone and with zidovudine (
TC both once daily plus bid/Short-term efficacy and safe
a in patients treated with (IDV)/Hyperbilirubinemia in pati
eated with d4T + 3TC + (IDV)/Long-term follow-up of a c

22465
60425
24108
33505
33527
23595
12391
12342
60274
12399
12273
12311
12317
12335
12350
22361
42276
60484
11185
12102
12200
126*/12221
132*/12237
12238
12265
292*/12267
12279
12286
12290
12292
12306
12324
12328
12329
12332
12337
12357
12359
12372
12379
12384
12388
12394
12396
14339
22269
22336
22337
22339
22343
22352
22356
22371
22372
22393
22403
22404
32172
32221
32308
512*/32330
41140
42169
42197
42266
42272
42275
60181
60358
60678
60808
60875

IDS at the workplace in Indian industry confederation of Indian ind
unreached women - An experience/Reaching unreached w
Psycho-social profile in HIV seropositive women/Psycho-s
t AIDS case in Brazilian populations/Surveillance of first Al
n with CMV and EBV in patients with HIV/AIDS/Co-infectio
Cardiac involvement in HIV population/Cardiac involveme
GO's experience in the context/Establishing counselling in
mong truckers on north highways/Prevention of HIV/AIDS/
s a surrogate marker in HIV population/CD4 counts as a su
ue herbal formulation in HIV patients: A pilot study/Effect of
ention in a rural Arizona tribe/HIV/AIDS and STD preventio
e role of Shamans and leaderships from de State of Sao P
ulnerability among the population of the State of Sao Paulo
py: Inaccessibility in the context/Combination drug therapy:
mic among truckers on trucking industry/An assessment of
nd lamivudine in South HIV-1 infected patients/Evaluation
erminants of behaviour/ society has some of the most uniqu
vention sensitive to the ethnicity/Developing therapeutic in
g oral candidiasis as an indicator of HIV disease in children/Persis
monia as an initial AIDS disease among adults in Californ
ry of life in prison as an of risk from HIV infection/AIDS i
cess and quality of care for HIV disease/The PCP index:
f mycobacteria growth tube and Lowenstein-Jensen me
ART is an unpredictable of BCM anabolism or catabolism
S prevention programs/ Indicators for evaluating the AIDS prevent
nd virologic markers as of clinical outcome in patients e
munologic and clinical of disease progression in a peri
a/HIV/STD prevention and sexual behaviour of the ge
AIDS and development /The AIDS and development

13439
23463
23482
23579
31204
32278
33260
33374
42194
42385
43162
43296
43335
44177
44201
60189
60912
60926
12196
22185
23555
24185
41169
60517
43531
12234
13368
14126
24119